Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Ipilimumab
Related studies linked through entity extraction aliases.
Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma
- Status
- TERMINATED
- Phase
- PHASE2
MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery
- Status
- COMPLETED
- Phase
- PHASE1